Gregory S. Curhan serves as Executive at Angion Biomedica Corp., where they oversee executive responsibilities. Since joining the company, Gregory S. Curhan has executed 1 insider transactions totaling $9.5K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 15, 2021 involved purchasing 4,000 shares valued at $9.5K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Dec 15, 2021 | ANGN | $9.5K | Purchase | 4,000 | $2.37 | Discretionary |
Gregory S. Curhan currently holds 4,000 shares of Angion Biomedica Corp. (ANGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gregory S. Curhan has been a net buyer of ANGN stock. They have purchased $9.5K and sold $0 worth of shares.
Gregory S. Curhan's most recent insider trade was on Dec 15, 2021, when they purchased 4,000 shares at $2.37 per share.
Get notified when new Form 4 filings are submitted